Mebendazole CAS: 31431-39-7
MF: C16H13N3O3
MW: 295.29
An antihelmintic small molecule compound.

Mebendazole (CAS 31431-39-7)

Mebendazole | CAS 31431-39-7 is rated 5.0 out of 5 by 1.
  • y_2020, m_6, d_30, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.9
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204798, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 14ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
Application: Mebendazole is an antihelmintic small molecule compound
CAS Number: 31431-39-7
Purity: ≥98%
Molecular Weight: 295.29
Molecular Formula: C16H13N3O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Mebendazole is an anthelmintic.


References

Apt W. Rev Med Chil. 118:1021-7 (1990).

Physical State :
Solid
Solubility :
Soluble in formic acid.
Storage :
Store at room temperature
Melting Point :
287° C
Boiling Point :
523.14° C (Predicted)
Density :
~1.4 g/cm3 (Predicted)
Refractive Index :
n20D 1.70 (Predicted)
pK Values :
pKa: 10.52 (Predicted), pKb: 4.7 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
EY8600000
PubChem CID :
4030
Merck Index :
14: 5768
MDL Number :
MFCD00057872
EC Number :
250-635-4
Beilstein Registry :
759809
SMILES :
COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Mebendazole (CAS 31431-39-7)  Product Citations

See how others have used Mebendazole (CAS 31431-39-7). Click on the entry to view the PubMed entry .

Citations 1 to 2 of 2 total

PMID: # 30664786  Liu, PH.|Shah, RB.|Li, Y.|Arora, A.|Ung, PM.|Raman, R.|Gorbatenko, A.|Kozono, S.|Zhou, XZ.|Brechin, V.|Barbaro, JM.|Thompson, R.|White, RM.|Aguirre-Ghiso, JA.|Heymach, JV.|Lu, KP.|Silva, JM.|Panageas, KS.|Schlessinger, A.|Maki, RG.|Skinner, HD.|de Stanchina, E.|Sidi, S.| et al. 2019. Nat. Cell Biol.

PMID: # 23667708  Lee, YJ. et al. 2013. PLoS ONE. 8: e64337.

Citations 1 to 2 of 2 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 111ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Wang Wang, J. et al. (PubMed 24587248) reported that Mebendazole reduces vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice. -SCBT Publication Review
Date published: 2015-02-12
  • y_2020, m_6, d_30, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.9
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204798, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 12ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.